tirzepatide menopause New research from a Mayo Clinic–led study suggests that postmenopausal women using hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight and obesity. In Menopause: GLP-1 Drugs, Hormone Therapy

10.1126/science.122.3157.32 74 BrahmaR.RaghuramanH

Peptides are short chains of amino acids that act like instructions for your cells

Custom GLP-1 Dosing for Kidney Disease Personalized GLP-1 dosing for CKD patients with monitoring, dehydration and hypoglycemia risk mitigation, and guidance across all kidney disease stages

Mounjaro comparison

Youre the expert on how your gut feels

Use of a short-acting testosterone formulation (for example, testosterone gel) is recommended in patients with a large adenoma, as it leads to rapid reversal of adverse effects of combined dopamine agonists and testosterone (for example, irritability or hypersexuality), should they develop